Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TXG: 10x Genomics, Inc. Stock Analysis | finqOS
Healthcare · Medical - Healthcare Information Services
The Story
TXG
The Story
TXG
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-1.3% / yr
Operating margin
-6.1%
ROIC
-4.2%
Financially safe
Stretched
Debt / equity
0.10×
Interest coverage
-6450.5×
Current ratio
5.90×
10x Genomics, Inc.
TXG
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
10x Genomics, Inc.
TXG
NASDAQ
·
USD
·
Closed
$47.27
−4.37%
$47.27
−$2.16 (4.37%)
52W Range
92th
pctl
Volume
0.82×
avg
Mkt Cap
6.00B
USD
P/E
-278.1
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
0.82×
avg
Market Cap
6.00B
USD
P/E Ratio
-278.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings